Grant: Doctoral Research Award : Priority Announcement - Global Health under CRPPHE
McMaster University
$120,000.00
Facilitating antibiotic stewardship: evaluating the trustworthiness, adaptability, and extent to which antimicrobial resistance is considered in antimicrobial evidence-based practice guidelines
FY 2024-25
Summary
Antimicrobial resistance (AMR) is a critical threat to global health that contributed to 4.95 million deaths in 2019. One of the main drivers of AMR is the misuse of antimicrobials. Because they include recommendations to guide clinicians, one tool to fight AMR are antimicrobial-related evidence-based practice guidelines (EBPG). To formulate EBPGs, panels of experts use research evidence to balance a series of factors including benefits, harms, and costs (among others) to determine which treatment should be recommended for a specific condition. Currently, it is unclear to what extent these panels consider AMR as one of the factors to be balanced.
To fill this gap, we aim to determine whether and how EBPGs are considering AMR, and to appraise how trustworthy these EBPGs are. Additionally, because developing new EBPGs is costly, we plan to assess if these existing EBPGs can be easily adapted so that researchers can take advantage of existing work. Finally, we will present our findings in a public, online database.
The applicant will focus on four prioritized infectious syndromes for feasibility: community-acquired pneumonia, urinary tract infections, skin and soft tissue infections, and exacerbations of chronic obstructive pulmonary disease. First, we will survey experts to develop a list of AMR considerations for EBPGs. Next, we will evaluate to what extent the EBPGs for the four prioritized syndromes address the identified AMR considerations. We will also evaluate the trustworthiness and adaptability of each EBPG using standardized tools. To present our work, we will work with knowledge users and a website developer to create a database. We will test this database with users before launching it.
This work will facilitate the development of future EBPGs by identifying what is already known and what limitations may exist for considering AMR in EBPGs. Through the development of our database, it will also facilitate usage of the best available evidence.
Department
Program
Doctoral Research Award : Priority Announcement - Global Health under CRPPHE
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
519392
Name
Ibrahim Sara
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Facilitating antibiotic stewardship: evaluating the trustworthiness, adaptability, and extent to which antimicrobial resistance is considered in antimicrobial evidence-based practice guidelines
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award : Priority Announcement - Global Health under CRPPHE
Keyworddelim
Antimicrobial Resistance; Critical Appraisal; Database Development; Delphi Method; Evidence Synthesis; Evidence-Based Practice Guidelines; Knowledge Translation; Recommendations; User-Testing
Abstract
Antimicrobial resistance (AMR) is a critical threat to global health that contributed to 4.95 million deaths in 2019. One of the main drivers of AMR is the misuse of antimicrobials. Because they include recommendations to guide clinicians, one tool to fight AMR are antimicrobial-related evidence-based practice guidelines (EBPG). To formulate EBPGs, panels of experts use research evidence to balance a series of factors including benefits, harms, and costs (among others) to determine which treatment should be recommended for a specific condition. Currently, it is unclear to what extent these panels consider AMR as one of the factors to be balanced.
To fill this gap, we aim to determine whether and how EBPGs are considering AMR, and to appraise how trustworthy these EBPGs are. Additionally, because developing new EBPGs is costly, we plan to assess if these existing EBPGs can be easily adapted so that researchers can take advantage of existing work. Finally, we will present our findings in a public, online database.
The applicant will focus on four prioritized infectious syndromes for feasibility: community-acquired pneumonia, urinary tract infections, skin and soft tissue infections, and exacerbations of chronic obstructive pulmonary disease. First, we will survey experts to develop a list of AMR considerations for EBPGs. Next, we will evaluate to what extent the EBPGs for the four prioritized syndromes address the identified AMR considerations. We will also evaluate the trustworthiness and adaptability of each EBPG using standardized tools. To present our work, we will work with knowledge users and a website developer to create a database. We will test this database with users before launching it.
This work will facilitate the development of future EBPGs by identifying what is already known and what limitations may exist for considering AMR in EBPGs. Through the development of our database, it will also facilitate usage of the best available evidence.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ibrahim, Sara
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~